If you’re reading this, you’re probably somewhere between week eight and week twelve on an SSRI, you’re trying to figure out whether it’s working, and you don’t entirely trust your own read on the question. That’s the right instinct. Your read on the question is genuinely hard to trust, and I’ll explain why in a minute. But first, the basics, because half of what’s confusing about month three is that nobody walked you through the timeline before you started.
SSRI stands for selective serotonin reuptake inhibitor. If you’re in Oregon or Washington and you got handed a prescription for depression or anxiety in the last few months, it’s almost certainly sertraline (Zoloft), escitalopram (Lexapro), or fluoxetine (Prozac). They’re cousins, they work on the same target, and the patient experience on them is more similar than different. None of what’s below is personalized medical advice, by the way. Talk to your prescriber. That’s literally their job, and if they brush you off when you bring this stuff up, that’s also useful information.
The 12-week timeline at a glance
Before we get into each phase in detail, here’s the rough shape of what most people experience. Your mileage will vary on any individual line, but this is the general arc.
| Window | Side effects | Mood and energy | What you’re tracking |
|---|---|---|---|
| Weeks 1-2 | Worst stretch. Nausea, headache, sleep weirdness, jittery feeling, vivid dreams. Sexual side effects show up early. | Often no change, sometimes briefly worse. Benefit hasn’t kicked in yet. | Can you tolerate the side effects long enough to get to the benefit window. Take with food, sleep when you can. |
| Weeks 2-4 | Nausea and headaches easing. Sleep starting to normalize. Jitter backing off. Sexual side effects still there. | Early signs of stabilization. Bad days still happening but slightly less intense. | Whether the body is adjusting to the drug or whether one specific side effect is getting worse instead of better. |
| Weeks 4-8 | Most of the early side effects are gone. Sexual side effects persist. Emotional blunting may appear. | Bad days less frequent, less severe. Mornings easier. You’re not sure if you feel better or just less bad. | The frequency and severity of the bad days, not the daily vibe. Whether emotional blunting is a feature or a problem. |
| Weeks 8-12 | Stable side effect profile. What’s still around at week 12 is probably what’s staying. | This is where evaluation happens. Real change is measurable here if it’s going to happen. | PHQ-9 score versus baseline. Residual symptom load. Whether to continue, adjust, augment, or switch. |
Weeks one through three: side effects first, benefit later
Here’s the thing nobody tells you up front, or they tell you and you don’t really hear it because you’re sitting in a chair feeling like garbage and you want the bad feeling to stop. The side effects of an SSRI hit first. The benefit lags. By a lot. So the first two or three weeks are the worst possible deal, pharmacologically: you get all the cost and none of the benefit, and you’re supposed to just trust that the curve eventually flips.
What does “cost” actually look like in those first few weeks? Nausea is the big one. Most people get some, some people get a lot, and it’s usually worst in the first ten days. Take it with food. Sleep gets weird, usually in the direction of either way too much or way too little, and your dreams can get strange and vivid in a way that’s slightly off-putting but isn’t medically alarming. Headaches are common. So is a kind of low-grade jittery feeling, like you drank one too many cups of coffee, that you weren’t expecting from a drug that’s supposed to calm you down.
Sexual side effects show up almost right away for most guys. Delayed orgasm, reduced libido, sometimes erectile changes. If we’re being honest, this one almost never fully goes away on the SSRI, and we’ll come back to it, because it’s the side effect people are least likely to bring up with their prescriber and most likely to quietly quit the medication over.
None of this is the medication being wrong for you. This is just what starting an SSRI feels like for most people, and the body adjusts. The question is whether you can hold on long enough for the adjustment to happen, which is roughly the next phase.
Weeks four through eight: the side effects ease, the mood shifts
Somewhere between week three and week six, most people notice the nausea is gone, the headaches have backed off, sleep has more or less normalized, and the jittery feeling has settled. The sexual side effects are still there. The vivid dreams might still be there. But the day-to-day discomfort of being on the drug stops being the main story.
At the same time, something else starts to happen, and this is the part that’s actually hard to describe to people who haven’t been through it. The bad days stop hitting as hard. The bottom drops out less often. The thing where you wake up at 4 a.m. with your chest tight and your brain running worst-case scenarios on loop, it happens less, or it still happens but you can get back to sleep faster, or it stops happening on a Tuesday for no reason. You don’t notice it the way you’d notice a switch flipping. You notice it later, like you notice that you stopped getting headaches three weeks after you started drinking water like you actually like it.
There’s also a thing called emotional blunting that shows up around this window, and it’s worth naming because it confuses a lot of people. The short version: SSRIs can take the top off your emotional range. Things that used to make you cry don’t. Things that used to make you furious only get you mildly annoyed. For some people this is a feature, because what was bringing them in was an emotional intensity that was wrecking their life. For other people it’s the main reason they end up quitting the medication, because they feel less like themselves. It’s not a malfunction. It’s a real thing the drug does, and it’s worth tracking honestly.
Weeks eight through twelve: the real evaluation window, and the moving baseline problem
This is where you are right now, probably, if you’re reading this. Week eight to week twelve is when the question gets asked seriously: is this drug doing its job, and if so, by how much?
The honest answer is that you, the person taking the medication, are not the best-positioned observer of your own response. That’s not an insult. It’s a structural problem. The reason is something called the moving baseline.
The moving baseline problem, or: wait, am I better?
Here’s how the moving baseline works. When you started the SSRI, your “normal” was a guy who had bad days three times a week, slept badly twice a week, snapped at his wife or his coworker or the guy at the gas station maybe once a week, and spent a chunk of every Sunday in a kind of low-grade dread about Monday. That was your reference point. That’s what “regular life” felt like to you, because you’d been living in it long enough that you’d stopped clocking it as abnormal.
Twelve weeks in, the bad days are happening once a week instead of three. The sleep is mostly fine. You haven’t snapped at anyone in two weeks. Sunday isn’t great but it isn’t a black cloud anymore. And here’s the trick: you don’t experience this as “I’m better.” You experience it as “I’m fine, I’ve always been fine, the medication isn’t really doing much.” Because your sense of normal recalibrates without telling you it recalibrated. The bad days you stopped having don’t show up on your mental ledger, because they didn’t happen.
This is why prescribers ask you to fill out the same questionnaire every time you come in. The most common one for depression is the PHQ-9, which is a nine-question screener that spits out a number from 0 to 27. You filled one out the day you started, and the number was something like 18, which is moderately severe. The whole point of filling it out again at week six and week twelve is to get a number that isn’t filtered through your moving baseline. If you came in at 18 and now you’re at 8, that’s not nothing. That’s a real change you might not feel because you’ve already adjusted to it.
The bad days you stopped having don’t show up on your mental ledger, because they didn’t happen. You don’t feel relief. You feel like you’ve always been fine. That’s the trap.
What “response” and “remission” actually mean
In the research literature, two words get thrown around that are worth knowing, because if your prescriber uses them they’re not using them loosely.
Response means at least a 50 percent reduction in symptom severity from where you started. So if your PHQ-9 was 18 at baseline and it’s 9 or lower at week twelve, you’re a responder. The drug is doing something measurable.
Remission means your scores are now in the normal range. For the PHQ-9, that’s usually 4 or below. Remission is the goal, not just response, because the people who hit remission are the ones whose risk of relapse is lowest and whose lives function the most normally. Plenty of people get to “response” and stop there, which is fine, but if you’re at response and not remission, there’s usually more work to do.
If you’re still at baseline at week twelve, meaning your number hasn’t budged, that’s the trigger point. That’s when the conversation with your prescriber stops being “let’s give it more time” and starts being “let’s change something.” That something is usually one of three moves: increase the dose if you’re not on a maximum already, add another medication on top (this is called augmentation), or switch to a different antidepressant. There’s no shame or failure in any of those moves. We’ll get into why in a minute.
The subtler stuff: what to track that isn’t on the questionnaire
The PHQ-9 is good for depression severity but it doesn’t ask about a lot of the things that show up on an SSRI and that are worth flagging. A short list of what to actually pay attention to as you get to month three:
Gut changes. Most of your serotonin lives in your gut, not your brain, which is one of those facts that sounds like internet nonsense but is actually true. SSRIs can change how your gut moves. Some people get loose stools, some people get the opposite, some people get a kind of low-grade nausea that comes and goes. If it’s mild and stable, it’s usually fine. If it’s getting worse or it’s interfering with eating, mention it.
Weight. SSRIs can move weight in either direction. Some people gain, some people lose, most people don’t change much. The mechanism isn’t entirely clear and the effect varies by drug. Sertraline tends to be more weight-neutral. Paroxetine, which you’re probably not on, is the one most associated with gain. Track the trend, not the daily number.
Sleep. By month three, sleep should have settled. If you’re still sleeping ten hours and waking up tired, or you’re still up at 3 a.m. every night, that’s worth bringing up. Sometimes the fix is taking the medication in the morning instead of at night, or vice versa. Sometimes it points to a different problem the SSRI isn’t solving.
Sexual function. I said earlier this almost never fully goes away on the medication, and that’s the honest truth. For most guys it’s some combination of delayed orgasm, reduced libido, or both. Bring it up. There are workarounds, including dose timing, dose adjustment, switching to a different antidepressant (bupropion has the cleanest sexual side effect profile, but it’s a different class of drug), and in some cases adjunctive medications. Do not just quit the SSRI over this without telling your prescriber. There are better moves.
Affect blunting. Already covered above. If you feel less like yourself in a way you don’t like, that’s a real reason to have a conversation about whether this is the right drug.
Irritability that wasn’t there before. A small subset of people get more snappish on an SSRI, not less. This is more common in people whose underlying issue had an irritable or activated component to it. If you’re more short-tempered at week ten than you were at week one, that’s signal.
When to call your prescriber today, not at your next appointment
Most of what’s above is the kind of thing you bring up at your next scheduled visit. There’s a smaller list of things that warrant a phone call now, not later.
- New or worsening thoughts of suicide. This is rare on SSRIs but it’s real, and it’s most likely in the first four weeks, especially in people under 25. If you’re noticing thoughts of suicide that weren’t there before, or thoughts that were vague are getting more specific, call. Don’t wait, don’t sit with it, don’t decide whether it’s bad enough. Call.
- Akathisia. This is a word for a specific kind of inner restlessness that’s hard to describe if you haven’t had it. It’s not anxiety in the usual sense. It’s a feeling like you cannot sit still, like you have to keep moving, like your skin is humming. It’s distinct from feeling jittery in the first week. If you’re getting this and it’s getting worse, that’s a reason to call, because severe akathisia is genuinely awful and there are interventions for it.
- Signs of serotonin syndrome. Serotonin syndrome is what happens when there’s too much serotonin activity at once, usually because you got prescribed something that interacts badly with your SSRI. The classic picture is some combination of high fever, muscle rigidity, tremor, agitation, confusion, racing heart, and sweating. If you’re getting several of those at once, especially if you recently started a new medication or a new supplement, this is an emergency room conversation, not a phone call.
- Severe allergic reaction. Rash, swelling of the face or throat, trouble breathing. Same answer, emergency room.
The honest framing nobody quite wants to give you
SSRIs help most people who start them. They are also not magic, and the response rate is roughly 50 to 65 percent depending on which study you read and how strictly you define response. Said plainly: about half of people who start an SSRI get meaningfully better on the first one they try. The other half need either a higher dose, a second medication added on, or a switch to a different drug entirely.
That is not a failure. That is the base rate. If you’re in the half that didn’t respond to the first try, you are in a completely normal place, and the next move is just the next move. STAR-D, which is the big federally-funded study that everyone in the field references, showed that response rates climb meaningfully when you add a second step. If the first SSRI didn’t do it, the second medication often does. If the second one doesn’t, the third one might, especially if you switch classes.
The reason it matters to know this going in is that a lot of guys hit week twelve, decide the drug didn’t work, and quietly stop taking it without telling anyone. That’s the worst possible outcome, for two reasons. One, stopping an SSRI cold turkey can produce a stretch of genuinely unpleasant discontinuation symptoms (dizziness, brain zaps, irritability, flu-ish feeling) that have nothing to do with the underlying depression or anxiety coming back. Two, you’ve now learned nothing about what your nervous system actually needs, because you didn’t have the conversation that would have let you take the next step.
What to bring to your month-three visit
If you’ve got an appointment coming up at the end of month three, the most useful thing you can do is show up with three pieces of information.
First, your honest sense of where the bad days are now compared to where they were at baseline. Not “I feel fine,” not “it isn’t working,” but a count. How often is the dread hitting. How often is the sleep getting wrecked. How often are you snapping at people. Numbers, not vibes, because of the moving baseline thing.
Second, the side effects that are still around at month three, especially the ones you’re tempted not to mention. Sexual function, affect blunting, gut stuff. These are the ones that determine whether this is sustainable for the next year or whether something needs to change.
Third, a question, not a verdict. “Where do you think we are on this drug” is a more useful sentence than “this isn’t working” or “I want to stop.” Your prescriber has the PHQ-9 numbers and the clinical context. You have the lived experience. Both pieces are needed to make the call.
Month three isn’t the finish line. It’s the checkpoint where you and your prescriber figure out whether to keep going as-is, adjust, or change tracks. If we’re being honest, the people who do best on these medications are the ones who treat them like a tool that needs calibration, not a verdict that’s been handed down about who they are. The drug isn’t your identity. It’s a thing you’re using, on purpose, for a reason, and the reason is still the same reason that brought you in.
Nothing above is personalized medical advice. If something in this article surfaced a question for you, the move is to call your prescriber, not to make a change on your own. SSRIs are well-tolerated by most people, but the dose, the drug, and the timing are decisions that need a clinician’s eyes on your specific case.